Fingerprint
Dive into the research topics of 'Adjuvant pazopanib does not PROTECT against recurrence of high-risk, initially localized renal cell cancer but does provide novel insights'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically